AR122928A1 - 1,6-naftiridinas sustituidas inhibidoras de cdk5 - Google Patents

1,6-naftiridinas sustituidas inhibidoras de cdk5

Info

Publication number
AR122928A1
AR122928A1 ARP210101930A ARP210101930A AR122928A1 AR 122928 A1 AR122928 A1 AR 122928A1 AR P210101930 A ARP210101930 A AR P210101930A AR P210101930 A ARP210101930 A AR P210101930A AR 122928 A1 AR122928 A1 AR 122928A1
Authority
AR
Argentina
Prior art keywords
alkyl
ring
optionally substituted
c4alkylene
hydroxyalkyl
Prior art date
Application number
ARP210101930A
Other languages
English (en)
Spanish (es)
Inventor
Goran Malojcic
Matthew H Daniels
Brett W Williams
Maolin Yu
Mark W Ledeboer
Jean Harmange
P - Wang Jenna Lijie Christophe
Original Assignee
Goldfinch Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goldfinch Bio Inc filed Critical Goldfinch Bio Inc
Publication of AR122928A1 publication Critical patent/AR122928A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP210101930A 2020-07-10 2021-07-08 1,6-naftiridinas sustituidas inhibidoras de cdk5 AR122928A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063050378P 2020-07-10 2020-07-10

Publications (1)

Publication Number Publication Date
AR122928A1 true AR122928A1 (es) 2022-10-19

Family

ID=79552168

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101930A AR122928A1 (es) 2020-07-10 2021-07-08 1,6-naftiridinas sustituidas inhibidoras de cdk5

Country Status (3)

Country Link
AR (1) AR122928A1 (fr)
TW (1) TW202212338A (fr)
WO (1) WO2022011274A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023231966A1 (fr) * 2022-05-30 2023-12-07 赛诺哈勃药业（成都）有限公司 Utilisation d'un dérivé de tétrahydronaphtyridine pour préparer un produit permettant d'améliorer l'hyperpigmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE286053T1 (de) * 1997-08-20 2005-01-15 Warner Lambert Co Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
US7323460B2 (en) * 2002-03-15 2008-01-29 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors
EP2155748A1 (fr) * 2007-05-15 2010-02-24 Boehringer Ingelheim International GmbH Antagonistes de récepteur d'urotensine ii
GB201007203D0 (en) * 2010-04-29 2010-06-16 Glaxo Group Ltd Novel compounds
GB201216018D0 (en) * 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Pharmacologically active compounds
KR20220099958A (ko) * 2019-10-01 2022-07-14 골드핀치 바이오 인코포레이티드 Cdk5의 치환된 1,6-나프티리딘 억제제

Also Published As

Publication number Publication date
WO2022011274A1 (fr) 2022-01-13
TW202212338A (zh) 2022-04-01

Similar Documents

Publication Publication Date Title
ES2905981T3 (es) Compuestos y composiciones como inhibidores de los receptores de tipo Toll endosomales
CA3007412C (fr) Utilisation de composes de pyridazine 1,4-disubstituee pour traiter la maladie de huntington
ES2963417T3 (es) Derivados de imidazol condensados como moduladores de IL-17
ES2788856T3 (es) Composiciones de pirrolopirrol como activadores de quinasa de piruvato (PKR)
ES2741896T3 (es) Compuestos de heterociclilo
ES2673405T3 (es) Derivados de Piridina Pirazolo como inhibidores de la NADPH oxidasa
HRP20161319T1 (hr) Derivati 8-karbamoil-2-(2,3-disupstituirani pirid-6-il)-1,2,3,4-tetrahidroizokinolina kao sredstva za izazivanje apoptoze za liječenje karcinoma i imunih i autoimunih bolesti
ES2606016T3 (es) Derivados de piperidina condensados en espiro para su uso como inhibidores del canal de potasio medular externo renal
ES2384365T3 (es) Nuevos derivados de indolin-2-ona sustituidos y su uso como inhibidores de la quinasa activada por mitógenos P38
ES2560611T3 (es) Derivados de fenil de azetidinilo, carboxamida de piridilo o pirazinilo como inhibidores de JAK
ES2602111T3 (es) Inhibidores de acetil-CoA carboxilasas de N1-pirazoloespirocetona
AR110421A1 (es) Derivados de pirazol como inhibidores de malt1
AR127309A2 (es) Derivados de piridazinona
CA3085761A1 (fr) Composes de 6-azaindole
AR122928A1 (es) 1,6-naftiridinas sustituidas inhibidoras de cdk5
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
JP2015537010A5 (fr)
JP2015508075A5 (fr)
AR043181A1 (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxiptamina-6
MX2012005100A (es) Derivados de heteroarilo que contienen n como inhibidores de cinasa jak3.
RU2015122894A (ru) Пуриновые ингибиторы фосфатидилинозитол-3-киназы дельта человека
CA2780018C (fr) Composes de pyrazolopyrimidine et de purine n-7-substitues, compositions et procedes d'utilisation correspondants
RU2016137789A (ru) ПРОИЗВОДНЫЕ N2-(2-ФЕНИЛ)-ПИРИДО[3,4-d]ПИРИМИДИН-2,8-ДИАМИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ MPS1 ИНГИБИТОРА
BR112021002408A2 (pt) carboxamidas como inibidores da protease específica de ubiquitina
ES2588835T3 (es) Compuestos de pirazol como inhibidores de SGLT1

Legal Events

Date Code Title Description
FB Suspension of granting procedure